(Q40404036)

20 September 2017

title

Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes (English)

1 reference

20 September 2017

0 references

0 references

1 reference

Nash KL

1

1 reference

20 September 2017

Alexander GJ

series ordinal

2

1 reference

20 September 2017

Lever AM

series ordinal

3

1 reference

20 September 2017

publication date

1 July 2005

1 reference

Journal of Viral Hepatitis

20 September 2017

published in

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

346-356

1 reference

More than third of world's population has been infected with hepatitis B virus

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Hepatitis B reactivation after lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Sequence requirements of the hammerhead RNA self-cleavage reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Green fluorescent protein: green cells do not always indicate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Intracellular application of hairpin ribozyme genes against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Targeted inhibition of hepatitis B virus gene expression: a gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Repression of hepatitis B virus X gene expression by hammerhead ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Use of the polymerase chain reaction for the sensitive detection of St. Louis encephalitis viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

A small catalytic oligoribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00612.X

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.84.4.1005

Identifiers

DOI

10.1111/J.1365-2893.2005.00612.X

1 reference

20 September 2017

1 reference